Repetitive Transcranial Magnetic Stimulation (rTMS) for Anxiety (rTMSinCP Trial)

"This trial is limited to a total of 20 participants who have achieved remission from cancer, and are aged between 22 and 80."

"Patients who meet the qualifications for this trial must be between 22 and 80 years of age. For those younger than 18 or older than 65, there are 263 and 1172 clinical trials available respectively."

"As per clinicaltrials.gov, this medical study is not presently recruiting patients; the trial was started on December 1st 2012 and most recently updated on January 11th 2023. Despite this, there are a multitude of other trials that need participants at present - 1589 to be exact."

"This trial's primary outcome is the relative modification in depression severity over a 6 week period. Secondary metrics include changes to anxiety levels (as gauged by the Hamilton Anxiety Rating Scale) between treatment arms, overall alteration of anxiety scores among both groups and the correlation between initial anxiety scores and final depression results for each arm."